[Enhanced Dewaterability of Waste-Activated Sludge in Presence of Fe(â ¡)-Activated Calcium Peroxide].

Ferrous iron-activated calcium peroxide (Fe2+/CaO2) was innovatively put forward to improve the dewaterability of waste-activated sludge. The effects of initial pH, Fe2+, and CaO2dosages on sludge dewatering performance were investigated and its internal mechanism for achieving deep sludge dewatering was thoroughly explored. The results indicated that the best dewatering performance was obtained by dosing 3.31 mmol·g-1 Fe2+ and 3.68 mmol·g-1 CaO2 under neutral pH, in which specific resistance to filtration (SRF) and water content (WC) reduced from 20.99×1012 m·kg-1 and 86.61% to 3.91×1012 m·kg-1 and 76.15%, respectively. Fe2+/CaO2 oxidation caused sludge microbial cell lysis, release of intracellular organic matter, and degradation of extracellular polymeric substances (EPS). Meanwhile, the generated Fe3+ facilitated re-flocculation of sludge particles into rigid and porous structure flocs, which was beneficial to the release of EPS-bound water to achieve deep sludge dewatering. From the perspective of technology and economy, the Fe2+/CaO2 process is economical and practical, and has a promising application prospect in improving the dewatering performance of waste-activated sludge.

[Distribution Characteristics of Disinfection By-Products and the Effects of Booster Chlorination in Long-Distance Water Supply Systems].

It is difficult for waterworks that add chlorine into finished water once to maintain sufficient residual chlorine at unfavorable points of the pipe network that supply water for large areas of coverage. Therefore, booster chlorination was employed for a long-distance water distribution system. The study was performed in H City with a water supply system serving about 400 km2 of downtown and rural areas. The purpose of this work is to obtain the distribution characteristics of disinfection by-products (DBPs) in the booster chlorination disinfection pipe network through uniformly distributed sampling analysis. The results showed that detected DBPs include trichloromethane (TCM), bromodichloromethane (BDCM), dibromochloromethane (DBCM) and tribromomethane (TBM), dichloroacetic acid (DCAA), trichloroacetic acid (TCAA), dichloroacetonitrile (DCAN), bromochloroacetonitrile (BCAN), and trichloronitromethane (TCNM). The concentrations of the regulated DBPs were found to be lower than the standard limits specified in the Sanitary Standard for Drinking Water (GB5749-2006). Before booster chlorination, the average concentrations of the DBPs mentioned (expressed as mean±deviation) were (8.08±3.34), (9.77±2.91), (7.38±4.82), (2.65±2.02), (2.95±3.26), (6.02±6.06), (3.13±2.48), (1.61±2.05), and (0.15±0.10) µg·L-1, while afterwards, they were increased to (10.30±4.55), (11.73±3.60), (8.23±5.22), (2.95±2.45), (3.29±3.60), (8.15±7.58), (3.31±2.61), (1.33±2.04), and (0.12±0.06) µg·L-1, respectively. Trihalomethanes (THMs) and haloacetic acids (HAAs) increased by 6.32%-26.60% and 5.32%-42.71%, respectively, after booster chlorination. In addition, raw water quality and seasonal changes had a certain impact on the occurrence of DBPs. The levels of DBPs in summer were generally higher than those in spring or autumn. According to the analysis of DBP formation potential of source water, finished water, and tap water, it was found that the risk of DBPs exceeding the standard limit may exist in the water supply system of H City; therefore, further optimization of the treatment process should be considered to ensure water quality.

Analysis of indoleamine 2-3 dioxygenase (IDO) and EGFR co-expression in breast cancer tissue by immunohistochemistry.

BACKGROUND: To determine the amount of co-expression of IDO and EGFR in breast cancer patients. MATERIALS AND METHODS: In order to obtain the distribution of co-expression of IDO and EGFR in breast cancer, we tested 110 breast cancer paraffin tissue blocks with immunohistochemical methods. Then we investigated the relationship between the diagnostic and pathologic characteristics (tumor size, lymph node status, histologic grade, the gene expression of ER, PR, HER2, p53, Ki67 and PCNA) with the situation of co-expression of IDO and EGFR by reviewing the medical records of 32 breast cancer patients. RESULTS: Among 110 breast cancers, 32 cases demonstrated IDO and EGFR co-expression (29.1%), IDO and EGFR synchronous co-expression being found in 19.1% and asynchronous in 10.0%. CONCLUSIONS: IDO and EGFR were co-expressed in breast cancer, including synchronous and asynchronous co-expression. The results suggest that considering IDO and EGFR as two indicators for breast cancer treatment or prognosis analysis provides a potential option of individual treatment for the portion of breast cancer patients with co-expression of IDO and EGFR.

[Soft and hard tissue changes after orthodontic and orthognathic treatment in patients with skeletal Class III malformation].

PURPOSE: To investigate soft- and hard-tissue changes and the association of these changes after orthodontic and orthognathic treatment in patients with skeletal Class III malocclusion. METHODS: The sample consisted of 20 patients with skeletal class III malocclusion treated with bilateral sagittal split ramus osteotomy (BSSRO). Lateral cephalograms taken before and after treatment were analyzed. All data were analyzed with SPSS13.0 software package for paired t test. RESULTS: The distances of SNB, B and Pog to Y axis was smaller and ANB was larger after treatment. The labiomental angle, the distances of TLL,SB and TC to Y axis were smaller(P<0.01). The two pairs of SB-B and TC-Pog had linear correlation. The ratio was 1:1 and 0.84, respectively. The coefficient of determination R2 value of SB-B was 0.96 and the other was 0.97. CONCLUSIONS: The patients with Class III malocclusion treated with orthodontic treatment and BSSRO can achieve satisfactory outcome. The single mandibular surgery did not affect the maxillary soft tissues. The changes of upper lip and lower lip length were not affected. The ratio of SB-B and TC-Pog corresponding soft- and hard-tissue ratio was 1:1 and 0.84, respectively. The coefficient of determination R2 values was all over 0.9.